Eris Lifesciences Debt & Borrowing: ₹109.1 Cr

Eris Lifesciences Investor Presentation: Key Takeaways

Q2 FY27 consolidated revenue ₹892 Cr (+12.6%), PAT ₹187 Cr (+39.2%), EBITDA margin 34.7%. H1 PAT ₹330 Cr (+27.3%). Zorvia out-licensing supports DBF gross margin.

Eris Lifesciences Q2 FY27 Results: Net Profit ₹187.1 Cr, Up 39.1% YoY

Eris Lifesciences Ltd reported revenue from operations of ₹892.4 Cr (+12.6% YoY) and net profit of ₹187.1 Cr (+39.1% YoY) for Q2 FY27.

Key figure

Net profit ₹187.1 Cr · +39.1% YoY

Eris Lifesciences Board Meeting Date

Eris Lifesciences has scheduled a board meeting for October 26, 2026, to consider and approve its unaudited standalone and consolidated financial results for the quarter ending September.

Eris Lifesciences Other Announcement

Eris Lifesciences Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.

Eris Lifesciences Debt & Borrowing: ₹1,250 Cr

Eris Lifesciences Limited submitted its half-yearly reporting of debt securities for the period ended September 30, 2026. Two tranches of NCDs totaling ₹1,250 Crore remain outstanding.

Value

₹1,250 Cr

Eris Lifesciences Management Change

Eris Lifesciences Limited announced the resignation of Mr. Krishnakumar Vaidyanathan from his roles as Executive Director and Chief Operating Officer. The resignation was effective September 30, 2026.

Fusion CX Debt & Borrowing: ₹21.85 Cr

Fusion CX lent up to Rs.21.85 Crore (USD 2.3 million) to wholly owned subsidiary Fusion BPO Services. Terms: 8.5% interest, three-year tenure, unsecured.

Value

₹21.85 Cr

Execution

3 years from the date of disbursal

Fusion CX Debt & Borrowing

Fusion CX Limited executed an unsecured inter-corporate term loan at 8.5% p.a. for three years with its wholly owned subsidiary Fusion BPO Services Ltd, a related party. Amount is not stated in the filing.

Execution

3 years from the date of disbursal

Spandana Sphoorty Financial Debt & Borrowing: ₹0.49 Cr

Spandana paid ₹0.49 Crore of quarterly interest on its secured NCDs on 27 October 2026. The coupon rate is 10.75% on a ₹50 Crore issue.

Value

₹0.49 Cr

Mangalam Worldwide Debt & Borrowing: ₹1.14 Cr

Mangalam Worldwide paid Rs. 1.14 Crore interest on its NCDs (ISIN INE0JYY07026) on 28 October 2026, net of TDS. The company confirmed timely payment under Regulation 57.

Value

₹1.14 Cr

Lloyds Metals & Energy Debt & Borrowing: ₹12,370 Cr

Lloyds Metals allotted 1,300 debt securities worth about ₹12,370 Crore on 29 October 2026. Three-year coupon is SOFR plus 450 bps, secured by Virtus Lloyds share pledges.

Value

₹12,370 Cr

Execution

3 years

Lloyds Metals & Energy Debt & Borrowing: ₹1,235 Cr

Lloyds Metals' committee approved terms for USD 130 million senior secured notes, about Rs.1,235 Crore. The notes mature in October 2029 at SOFR plus 450 bps.

Value

₹1,235 Cr